News & Press Releases
Filter by:
Mintz Secures Full Patent Victory for Kowa Pharmaceuticals and Nissan Chemical in Lengthy Battle
September 22, 2017
Mintz has secured a string of substantial victories in Hatch-Waxman litigation for innovative drug manufacturers Kowa Pharmaceutical Co., Ltd., Kowa Pharmaceuticals America, Inc., and Nissan Chemical Industries Ltd.
HHS Watchdog to Probe Medicaid Health Homes Program
September 20, 2017
Washington, D.C. health care attorney Ellyn Sternfield is quoted in a Bloomberg BNA article covering a new Medicaid home health program that is to be reviewed by the Health and Human Services (HHS), Office of the Inspector General (OIG).
Patent For Cholesterol Drug Livalo Is Valid, Judge Rules
September 20, 2017
Kathleen Carr and David Conlin, both Members in the Boston Mintz office and patent litigators, were featured in a Law360 article covering the ruling in the matter of a patent infringement trial against Amneal and Apotex.
Fourteen Mintz attorneys have been named New York Super Lawyers for 2017 and thirteen have been named New York Rising Stars. New York Super Lawyers recognizes the top lawyers with the highest degree of peer recognition and professional achievements.
Physician Practice Acquisitions And Antitrust Scrutiny
September 19, 2017
Chair of Mintz’s Antitrust section Bruce Sokler, along with Member Rob Kidwell and attorneys, Farrah Short Shawn Skolky collaborated on an article regarding the Washington state attorney general’s office suit against the expansion efforts of Franciscan Health System.
Selling your emerging life-science company: Earnouts and special holdbacks hitting your closing-date payout
September 18, 2017
New York Member James McKnight authored this column discussing what PE firms can do to secure their finances when facing earnouts and special holdbacks in selling emerging life-science companies.
Press Contact